首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >A phosphopantetheinylating polyketide synthase producing a linear polyene to initiate enediyne antitumor antibiotic biosynthesis
【2h】

A phosphopantetheinylating polyketide synthase producing a linear polyene to initiate enediyne antitumor antibiotic biosynthesis

机译:磷酸泛素化聚酮化合物合酶产生线性多烯以启动烯二炔抗肿瘤抗生素的生物合成

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The enediynes, unified by their unique molecular architecture and mode of action, represent some of the most potent anticancer drugs ever discovered. The biosynthesis of the enediyne core has been predicted to be initiated by a polyketide synthase (PKS) that is distinct from all known PKSs. Characterization of the enediyne PKS involved in C-1027 (SgcE) and neocarzinostatin (NcsE) biosynthesis has now revealed that (i) the PKSs contain a central acyl carrier protein domain and C-terminal phosphopantetheinyl transferase domain; (ii) the PKSs are functional in heterologous hosts, and coexpression with an enediyne thioesterase gene produces the first isolable compound, 1,3,5,7,9,11,13-pentadecaheptaene, in enediyne core biosynthesis; and (iii) the findings for SgcE and NcsE are likely shared among all nine-membered enediynes, thereby supporting a common mechanism to initiate enediyne biosynthesis.
机译:烯二炔以其独特的分子结构和作用方式统一起来,代表了迄今为止发现的一些最有效的抗癌药物。预测烯二炔核心的生物合成是由不同于所有已知PKS的聚酮化合物合酶(PKS)引发的。参与C-1027(SgcE)和新carcarinostatin(NcsE)生物合成的烯二炔PKS的表征现已揭示: (ii)PKS在异源宿主中有功能,并且与烯二炔硫酯酶基因共表达可在烯二炔核心生物合成中产生第一个可分离的化合物1,3,5,7,9,11,13-戊烯十碳烯; (iii)SgcE和NcsE的发现可能在所有九元烯二炔中共享,从而支持启动烯二炔生物合成的通用机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号